Trade Astrana Health Inc - ASTH CFD

Trading Conditions
Spread0.16
Long position overnight fee
Long position overnight fee

Margin. Your investment
$1,000.00
Overnight fee
Charges from full value of position
-0.026179 %
(-$1.05)

Trade size with leverage ~ $5,000.00

Short position overnight fee ~ $4,000.00


-0.026179%
Short position overnight fee
Short position overnight fee

Margin. Your investment
$1,000.00
Overnight fee
Charges from full value of position
0.003957 %
($0.16)

Trade size with leverage ~ $5,000.00

Short position overnight fee ~ $4,000.00


0.003957%
Overnight fee time21:00 (UTC)
CurrencyUSD
Min traded quantity1
Margin20
Stock exchangeUnited States of America
Commission on trade10%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close37.87
Open36.95
1-Year Change5.93%
Day's Range34.85 - 38.21

Apollo Medical Holdings, Inc. Company profile

About Apollo Medical Holdings Inc

Apollo Medical Holdings, Inc. is a healthcare management company, which operates an integrated healthcare model. The Company through its subsidiary provides care coordination services to each constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups and health plans. Its physician network consists of primary care physicians, specialist physicians, and hospitalists. It operates an integrated healthcare delivery platform that enables providers to participate in value-based care arrangements. To implement a patient-centered, physician-centric experience, the Company has other integrated and synergistic operations, including management service organizations (MSOs) that provide management and other services to its affiliated independent practice associations (IPAs), outpatient clinics, and hospitalists that coordinates the care of patients in hospitals.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Apollo Medical Holdings Inc revenues increased 13% to $773.9M. Net income increased 95% to $73.9M. Revenues reflect Medicare segment increase of 13% to $307.3M, Commercial segment increase of 27% to $138.3M. Net income benefited from Interest expense - Balancing value decrease of 43% to $5.4M (expense), Total Amort of Intangibles-excl Goodwill decrease of 4% to $15.4M (expense).

Equity composition

Common stock $0.001 Par, 11/10, 100M auth., 27,635,774 issd. Insider own 68.17%. Preferred stock $0.001 Par, 5Mauth. 04/15, 1-for-10 Reverse stock split.